Alpha-1 Antitrypsin Deficiency Treatment Study

Medical Condition: Alpha-1 Antitrypsin Deficiency

Facility/Clinic: Accellacare

Age: 18-75

Gender: Male/Female

Description: A research study that is evaluating an investigational medication that may slow the progression of alpha-1 antitrypsin deficiency in patients with emphysema. This research study may be an option if you:

  • Have a clinical diagnosis of alpha-1 antitrypsin deficiency
  • Have evidence of emphysema
  • Have been a non-smoker for at least 12 months or never smoked
  • Have no history of moderate to severe liver fibrosis

Other criteria apply. Please make sure to discuss this study with a member of our research staff to ensure this research study is a good fit for you. Qualified participants will receive all study-related care and study medication at no cost.

Enrollment: Open

Patient Commitment Duration: Approximately 5 months

Number of visits in study: Approximately 9 clinic visits and 2 phone calls

Patient Compensation: Financial compensation will be provided for time and travel expenses.

The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-362-4040 between the hours of 8am-5pm for general research questions.